2021-01-07,Cabaletta Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-04,Cabaletta Bio to Participate in Upcoming January Investor Conferences
2020-12-08,Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes Trial of DSG3-CAART for Treatment of Mucosal-Dominant Pemphigus Vulgaris
2020-12-04,Is Cabaletta Bio (CABA) A Good Stock To Buy Now?
2020-11-23,Cabaletta Bio to Participate in Upcoming December Investor Conferences
2020-11-10,Cabaletta Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-10-31,"Kaskela Law LLC Announces Stockholder Investigation of Cabaletta Bio, Inc. - CABA"
2020-10-22,"What Kind Of Investors Own Most Of Cabaletta Bio, Inc. (NASDAQ:CABA)?"
2020-09-25,Cabaletta Bio to Present at Upcoming Investor Conferences in October
2020-09-08,Cabaletta Bio to Present at Multiple Upcoming September Investor Conferences
2020-08-25,Cabaletta Bio Announces Publication of Comprehensive Preclinical Study Results for DSG3-CAART in Pemphigus Vulgaris
2020-08-06,Cabaletta Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-08-03,Cabaletta Bio to Present at Multiple August Investor Conferences
2020-07-24,We're Hopeful That Cabaletta Bio (NASDAQ:CABA) Will Use Its Cash Wisely
2020-07-07,Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies
2020-06-24,"Hedge Funds Keep Buying Cabaletta Bio, Inc. (CABA)"
2020-06-01,"Cabaletta Bio, Inc. (CABA) Moves to Strong Buy: Rationale Behind the Upgrade"
2020-05-28,Cabaletta Bio Announces Expansion of Sponsored Research Agreement with the University of Pennsylvania
2020-05-27,Cabaletta Bio to Present at Jefferies Virtual Healthcare Conference
2020-05-18,Cabaletta Bio Announces Presentation of Data Supporting MuSK-CAART Development for the Treatment of the MuSK form of Myasthenia Gravis at the AAN 2020 Science Highlights Virtual Platform
2020-05-12,Cabaletta Bio Reports First Quarter 2020 Financial Results and Provides Business Update
2020-05-06,Cabaletta Bio Receives FDA Fast Track Designation for DSG3-CAART for the Treatment of Mucosal Pemphigus Vulgaris
2020-04-17,"Cabaletta Bio, Inc. (CABA) Upgraded to Strong Buy: Here's What You Should Know"
2020-03-30,Cabaletta Bio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
2020-02-20,Cabaletta Bio to Present at the Cowen and Company 40th Annual Health Care Conference
2020-01-30,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance"
2020-01-29,FDA Grants DSG3-CAART Orphan Drug Designation for the Treatment of Pemphigus Vulgaris
2019-12-23,3 Stocks with Growth Prospects in the Triple Digits
2019-11-26,Cabaletta Bio to Present at the Evercore ISI 2nd Annual HealthCONx Conference
2019-10-25,Phathom Pharmaceuticals Rises Almost 30% After $182 Million
2019-10-25,Cabaletta Bio Announces Pricing of Initial Public Offering
